Can Systemic Anti-CD20 B Cell-Depleting Antibodies Eliminate Meningeal Follicles in Multiple Sclerosis?

por Gupta, Sasha, Zamvil, Scott S.
Publicado 2021

Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?

por Zamvil, Scott S., Slavin, Anthony J.
Publicado 2015

Unique invariant CD8(+) T cell population persists in MS

por Sabatino, Joseph J., Zamvil, Scott S.
Publicado 2015

Your nose knows how to target brain inflammation

por Winger, Ryan C., Zamvil, Scott S.
Publicado 2016

Aryl hydrocarbon receptor activity may serve as a surrogate marker for MS disease activity

por Sabatino, Joseph J., Zamvil, Scott S.
Publicado 2017

Do maternal anti–N‐methyl‐D‐aspartate receptor antibodies promote development of neuropsychiatric disease in children?

por Pröbstel, Anne‐Katrin, Zamvil, Scott S.
Publicado 2019

N2 year in review and message from the editor to our reviewers

por Dalmau, Josep, Kolson, Dennis L., Paul, Friedemann, Zamvil, Scott S.
Publicado 2018

Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?

por Maguire, Cole, Frohman, Teresa, Zamvil, Scott S., Frohman, Elliot, Melamed, Esther
Publicado 2020

The Gut Microbiome in Neuromyelitis Optica

por Zamvil, Scott S., Spencer, Collin M., Baranzini, Sergio E., Cree, Bruce A. C.
Publicado 2017

N2 year in review

por Dalmau, Josep, Dalakas, Marinos C., Kolson, Dennis L., Paul, Friedemann, Zamvil, Scott S.
Publicado 2019

N2 year in review

por Dalmau, Josep, Dalakas, Marinos C., Kolson, Dennis L., Paul, Friedemann, Zamvil, Scott S.
Publicado 2020

Relapsing Encephalomyelitis After COVID-19 Infection and Vaccination: From the National MS Society Case Conference Proceedings

por Roy, Shuvro, Barreras, Paula, Pardo, Carlos A., Graves, Jennifer S., Zamvil, Scott S., Newsome, Scott D.
Publicado 2023

Neither T-helper type 2 nor Foxp3(+) regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity

por Weber, Martin S, Prod’homme, Thomas, Youssef, Sawsan, Dunn, Shannon E, Steinman, Lawrence, Zamvil, Scott S
Publicado 2014

Acute liver injury in a Glatopa-treated patient with MS

por Sabatino, Joseph J., Mehta, Neil J., Kakar, Sanjay, Zamvil, Scott S., Cree, Bruce A.C.
Publicado 2017

B‐cell very late antigen‐4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity

por Lehmann‐Horn, Klaus, Sagan, Sharon A., Bernard, Claude C.A., Sobel, Raymond A., Zamvil, Scott S.
Publicado 2015

Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens

por Cree, Bruce A. C., Spencer, Collin M., Varrin‐Doyer, Michel, Baranzini, Sergio E., Zamvil, Scott S.
Publicado 2016

Targeting B cells to modify MS, NMOSD, and MOGAD: Part 2

por Graf, Jonas, Mares, Jan, Barnett, Michael, Aktas, Orhan, Albrecht, Philipp, Zamvil, Scott S., Hartung, Hans-Peter
Publicado 2020

Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1

por Graf, Jonas, Mares, Jan, Barnett, Michael, Aktas, Orhan, Albrecht, Philipp, Zamvil, Scott S., Hartung, Hans-Peter
Publicado 2020

N2 Year in Review

por Dalmau, Josep, Dalakas, Marinos C., Kolson, Dennis L., Paul, Friedemann, Sánchez-Valle, Raquel, Zamvil, Scott S.
Publicado 2023

Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate

por Spencer, Collin M., Crabtree-Hartman, Elizabeth C., Lehmann-Horn, Klaus, Cree, Bruce A.C., Zamvil, Scott S.
Publicado 2015